Evidence map›Paper›PMID 28319066›Full record

ArticleOncogene2017

Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis.

Y Zhang, Y-J Ren, L-C Guo, C Ji, J Hu, H-H Zhang, Q-H Xu, W-D Zhu, Z-J Ming, Y-S Yuan and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The role of acetylation and deacetylation in cancer metabolism.Clinical and translational medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. MiR-199a-3p promotes repair of myocardial infarction by targeting NACC2.International journal of clinical and experimental pathology · 2023
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Y ZhangDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
Y-J RenDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
L-C GuoDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
C JiDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
J HuDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
H-H ZhangDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
Q-H XuDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
W-D ZhuDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
Z-J MingDepartment of Pharmacology, College of Pharmaceutical Sciences, First Affiliated Hospital, Soochow University, Jiangsu, China.
Y-S YuanEngineering Research Center of Cell and Therapeutic Antibody, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
X RenDepartment of Pharmacology and Microbiology and Immunology, The Penn State Hershey Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
J SongDepartment of Pharmacology and Microbiology and Immunology, The Penn State Hershey Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA.ORCID 0000-0002-9734-6176
J-M YangDepartment of Pharmacology and Microbiology and Immunology, The Penn State Hershey Cancer Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Soochow University · CNPenn State Milton S. Hershey Medical Center · USShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleus accumbens-associated protein-1 (NAC1), a nuclear factor of the BTB/POZ gene family, has emerging roles in cancer. In this study, we identified the NAC1-HDAC4-HIF-1α axis as an important pathway in regulating glycolysis and hypoxic adaptation in tumor cells. We show that nuclear NAC1 binds to histone deacetylase type 4 (HDAC4), hindering phosphorylation of HDAC4 at Ser

Indexed as

AnimalsCell HypoxiaCell Line, TumorCell SurvivalDisease ProgressionFemaleGlycolysisHeLa CellsHistone DeacetylasesHumansHypoxia-Inducible Factor 1, alpha SubunitMiceNucleus AccumbensRepressor ProteinsTransfectionTumor MicroenvironmentHDAC4 protein, humanHistone DeacetylasesHypoxia-Inducible Factor 1, alpha SubunitRepressor Proteins

Identifiers

PMID28319066
PMCPMC5537617
OpenAlexW2601757086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.